Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients
- PMID: 32408391
- PMCID: PMC7272830
- DOI: 10.1111/jth.14902
Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients
Comment on
-
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27. J Thromb Haemost. 2020. PMID: 32220112 Free PMC article.
References
-
- Basu‐Ray I, Soos MP. Cardiac manifestations of coronavirus (COVID‐19). StatPearls. 2020. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical